PD-1 and Its Ligands Are Important Immune Checkpoints in Cancer

Oncotarget - United States
doi 10.18632/oncotarget.13895
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

108 Immune Checkpoints and Activation Molecules Including PD-1 Are Highly Conserved Across Mouse and Human TRM, and Co-Regulated by Runx3

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

The Blockade of Immune Checkpoints in Cancer Immunotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2012English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Concordance of Immune Checkpoints Within Tumor Immune Contexture and Their Prognostic Significance in Gastric Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2016English

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Comprehensive Transcriptome Profiling in Elderly Cancer Patients Reveals Aging-Altered Immune Cells and Immune Checkpoints

International Journal of Cancer
Cancer ResearchOncology
2018English

Intratumoral Immune Cells Expressing PD-1/PD-L1 and Their Prognostic Implications in Cancer: A Meta-Analysis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2018English

Toll-Like Receptors: Important Immune Checkpoints in the Regression of Cervical Intra-Epithelial Neoplasia 2

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy